Connect with us

Health

U.S. vaccination rate hits the highest pace in weeks – CTV News

Published

 on


The rate of COVID-19 vaccinations in the United States continues to rise, a positive sign amid skyrocketing cases and hospitalizations after weeks of lagging inoculations.

The U.S. Centers for Disease Control and Prevention reported Sunday that 816,203 additional doses were administered, the fifth straight day the agency recorded more than 700,000 shots in arms. That brings the total number of doses administered to 346,456,669, according to the CDC numbers released Sunday.

The seven-day average of administered doses is now 662,529 per day, the highest average since July 7.

Additionally, Sunday was the third day in a row that the seven-day average of people getting their first shots topped 400,000. The last time that metric was over 400,000 was the July Fourth weekend.

That’s still less than a quarter of the peak in mid-April, when nearly 2 million people were getting their first shot each day.

If the U.S. picked up vaccinations to the April pace, it would take only a month and a half to reach all eligible people.

Per CDC data released Sunday, 168.4 million people are fully vaccinated, or 49.6% of the U.S. population. Among vaccine-eligible Americans — meaning those who are 12 and older — 58.1% are fully vaccinated.

Dr. Francis Collins, director of the National Institutes of Health, hopes the recent surge in cases driven by the Delta variant is changing the minds of the vaccine hesitant, he told CNN’s Jake Tapper Sunday. Collins noted that in the last two weeks, vaccination rates have increased 56% nationally.

“This may be a tipping point for those who have been hesitant to say, ‘OK, it’s time,'” Collins said. “I hope that’s what’s happening. That’s what desperately needs to happen if we’re going to get this Delta variant put back in its place.”

Overall, the seven-day average of people becoming fully vaccinated each day is at 247,385 people per day.

Twenty states have now fully vaccinated more than half of their residents, including Colorado, Connecticut, Hawaii, Maine, Maryland, Massachusetts, Minnesota, New Hampshire, New Jersey, New Mexico, New York, Oregon, Rhode Island, Vermont, Virginia and Washington state, as well as Washington, DC.

On the other hand, the states with the lowest percentage of their population vaccinated are Alabama and Mississippi, which have 34% and 35% of their residents vaccinated, respectively.

Correction: An earlier version of this story and headline gave the wrong timing for when the doses were administered. The Centers for Disease Control and Prevention reported the additional doses Sunday, but it’s not clear when they were all administered.

The-CNN-Wire
™ & © 2021 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.

Adblock test (Why?)



Source link

Continue Reading

Health

Mass vaccination campaign against Monkeypox needed, experts say – Global News

Published

 on


As the World Health Organization calculates whether to declare monkeypox a global health emergency, infectious disease experts are urging health officials to be more proactive and start ramping up vaccinations and surveillance — especially in African nations where the virus is most prevalent.

The WHO convened its emergency committee Thursday to consider whether the spiralling outbreak of monkeypox should be declared a “public health emergency of international concern,” the WHO’s highest level of alert.

But the United Nations agency is facing criticism over its treatment of monkeypox — jumping into action only after the disease started to spread in rich western nations.

Read more:

WHO to discuss declaring monkeypox outbreak a global health emergency

The viral disease that causes flu-like symptoms and skin lesions is endemic in parts of Africa, which means it is consistently present in certain regions. The continent has registered just over 1,500 suspected cases since the start of 2022, of which 70 have been fatal, according to the WHO.

By comparison, Canada has confirmed over 200 cases, the majority of which are in Quebec, and has had no deaths.

“There are more cases that occur in Africa on a yearly basis than have already been reported outside of Africa right now. And there are more deaths that have occurred in Africa from monkeypox than have occurred in the rest of the world,” said Dr. Sameer Elsayed, an infectious disease physician and professor of epidemiology and biostatistics at Western University.

Read more:

Monkeypox in Canada: 211 confirmed cases reported across the country

That’s why he believes Africa should be getting the lion’s share of resources to deal with monkeypox — and that should include mass vaccinations, he says.

“I think Africa needs to be looked at with high, high priority,” he said.

“It needs to be a mass vaccination campaign for monkeypox with the newer vaccines for people in the African continent, especially in the high endemic areas.”

He’s not alone.

Dr. Monica Gandhi, a physician and infectious disease expert at the University of California, San Francisco, says she also believes more people living in regions where monkeypox is more prevalent should be vaccinated.

“That will actually stop it in endemic regions in this non-endemic outbreak.”

That the WHO is only now taking monkeypox seriously is “profoundly problematic,” Gandhi says, given that the disease has been spreading and killing people in Central and West Africa for years.


Click to play video: 'Monkeypox has about half of Canadians worried, but most confident with health response: poll'



0:29
Monkeypox has about half of Canadians worried, but most confident with health response: poll


Monkeypox has about half of Canadians worried, but most confident with health response: poll – Jun 17, 2022

“It’s been circulating since 1958. There are increasing outbreaks — a severe one in Nigeria, for example in 2017 — and it’s only really essentially when this has affected high-income countries that the WHO is jumping on it.”

Experts who have worked on monkeypox in places like the Democratic Republic of Congo have long taken note of rising cases while population immunity to pox viruses has been decreasing, due to lack of vaccination. This is why the world shouldn’t be surprised at the current outbreaks, said Anne Rimoin, an epidemiology professor at UCLA in California, who has studied monkeypox for two decades.

The COVID-19 pandemic has demonstrated how quickly a deadly virus can spread across the globe when the right conditions are present, so health officials ought to learn from this and start being more proactive, she said.

“When it comes to infectious diseases, in particular those viruses that have the potential for global spread, it’s much easier to stay out of trouble than it is to have to get out of trouble.”

In addition to providing vaccines, health officials should also be ramping up resources to study this disease and do more surveillance to get a better understanding of monkeypox and learn why it is spreading in new and unusual ways, Rimoin said.

Read more:

Monkeypox outbreak: Case count rises to more than 3,200 globally, says WHO

“We’ve given this virus a lot of runway to be able to spread. We have not been looking for it as vigilantly as we should be,” she said.

“I think we have to learn the lessons that we’ve learned with COVID-19 and that it is much better to invest ahead of time to get in front of these viruses, to do the kind of surveillance it’s necessary to be regularly updating our knowledge about viruses.”

Good disease surveillance is just as important in poorer countries as it is in “high-resource settings,” she added.

Like many countries around the world, Canada and the United States stopped vaccinating the general population against smallpox by around 1972, which means many on this continent are highly susceptible to pox viruses like monkeypox.

Given that scientists expect to see more emerging infectious diseases due to factors such as climate change, deforestation and globalization, the world should start getting better prepared for new outbreaks, Elsayed said.

Read more:

Monkeypox has Canadian researchers scrambling. Why, and how contagious is it?

This is why, in addition to calling for vaccinations and more resources to fight monkeypox in Africa, Elsayed believes governments in developed nations should also consider more options to protect citizens from pox viruses, including possibly re-introducing mass smallpox vaccinations.

“I believe that these vaccines should come on board again for the general population … but not (just) for monkeypox, but also to protect the world against perhaps a smallpox pandemic that can happen in the future, or even another virus that’s closely related to monkeypox but hasn’t reached humans,” Elsayed said.

He stressed this should only be considered after addressing the more pressing needs in Africa first.


Click to play video: 'WHO looks into reports of traces of monkeypox found in semen'



2:37
WHO looks into reports of traces of monkeypox found in semen


WHO looks into reports of traces of monkeypox found in semen – Jun 15, 2022

Rimoin noted that when the world stopped vaccinating against smallpox, it opened a “gap of immunity” for populations to once again be vulnerable to it. And with the emergence of a number of new pox viruses in different parts of the globe, including mousepox, cowpox and camelpox, the world is not immune to new outbreaks, she said.

“We now have to really think about, How important is it for us to be able to keep pox viruses out of the population?” she said. “What are the stakes of allowing this virus to spread? And then acting accordingly.”

-With files from Global News reporter Reggie Checcini and Reuters.

© 2022 Global News, a division of Corus Entertainment Inc.

Adblock test (Why?)



Source link

Continue Reading

Health

New Brunswick prepares for COVID-19 vaccine rollout for children under 5 – CBC.ca

Published

 on


New Brunswick will be ready to roll out COVID-19 vaccines to children under five as soon as they’re approved and available, according to the chief medical officer of health.

The province is also working on an early flu vaccination campaign in anticipation of “a higher than normal” influenza season this year, said Dr. Jennifer Russell.

In the U.S., immunization of infants and preschoolers against COVID-19 began this week after the Food and Drug Administration (FDA) authorized emergency use of the Moderna and Pfizer-BioNTech vaccines in children as young as six months old last Friday, and the Centers for Disease Control and Prevention (CDC) recommended use of the vaccines in this age group the following day.

No COVID-19 vaccine has been approved for children under five in Canada yet. Health Canada is reviewing an application from Moderna.

“We are waiting for Health Canada as well as NACI [National Advisory Committee on Immunization] to come forth with their recommendations,” said Russell.

The province is “watching very closely,” she said, and is “ready to act on those when they come through.”

Russell could not estimate when that might be.

“But we are preparing ahead of time for that inevitability.”

No details yet

Planning for the rollout is underway, said Department of Health spokesperson Michelle Guenard.

The department is working with its primary care partners, including the regional health authorities, community pharmacies and the New Brunswick Medical Society, she said.

No other details, such as where the shots will be available or who will administer them, are available yet.

“Final decisions will be made after Health Canada has given approval to the vaccine,” Guenard said in an emailed statement. “This includes reviewing a statement from NACI and local considerations.”

“Guidance will be provided to those identified to be immunizers for the under-five vaccinations,” she added. “This includes sharing information from Health Canada, the vaccine supplier, NACI and guidance from New Brunswick Public Health.”

‘Very encouraging’

Russell called the U.S. approval “very encouraging.”

“I think whatever protections we can provide to the population as a whole is very important,” she said. “This is one of the last pieces, really, that we’ve been waiting for.”

The under-five age group is the only one in the province that doesn’t currently have COVID-19 vaccines available to them.

Children aged five to 11 have been able to get a shot since November.

Dr. Jennifer Russell, the province’s chief medical officer of health, said with COVID-19 vaccines already available to New Brunswickers aged five and older, the pending approval for those under five is ‘one of the last pieces’ the province has been waiting for. (Ed Hunter/CBC)

“As we have seen with older age groups, we expect that the vaccines for younger children will provide protection from the most severe outcomes of COVID-19, such as hospitalization and death,” FDA commissioner Dr. Robert M. Califf said in a statement.

“Those trusted with the care of children can have confidence in the safety and effectiveness of these COVID-19 vaccines and can be assured that the agency was thorough in its evaluation of the data,” he said.

The FDA found the known and potential benefits of the Moderna and Pfizer-BioNTech COVID-19 vaccines “outweigh the known and potential risks in the pediatric populations.”

According to the clinical trial data, the most commonly reported side effects in children aged six months to five years old included pain, redness and swelling at the injection site, fever and underarm (or groin) swelling/tenderness of lymph nodes in the same arm (or thigh) as the injection.

Spike in flu cases

A total of 52.7 per cent of eligible New Brunswickers have received a COVID-19 booster shot, as of this week’s COVIDWatch report, 88.1 per cent have received two doses and 93.3 per cent have received one dose.

The province wants to have as many people protected as possible going into the fall, said Russell.

The “pattern of the pandemic” has been that the risks tend to decrease in the summer when people are outside more, physically distancing, and increase in the fall and winter, she said.

“I think that correlation is holding true at the moment but you know we try to be prepared for whatever comes our way with COVID because there aren’t any guarantees.

“We are aware that we’re expecting a higher than normal flu season this year and so we will be pushing our vaccination campaigns early.”

The red line indicates the growth in the percentage of positive influenza tests in New Brunswick. Yellow represents the Influenza A (H3)cases, while green illustrates Influenza A (unsubtyped). (Government of New Brunswick)

New Brunswick is dealing with an unusually late flu season, due in part to the lifting of COVID-19 protective measures in March, such as masking.

Normally, the flu season really starts to “take off” in January and “peters out” once the warmer weather begins, the province’s acting deputy chief medical officer of health Dr. Yves Léger has said.

But nearly a quarter of this season’s cases occurred in one week this month.

Seventy-three positive influenza cases were reported in week 23, which ended June 11, the most recent statistics available from Public Health show. Six of the cases required hospitalization.

Two new influenza outbreaks were reported in nursing homes and one new influenza-like illness outbreak was reported in a school, the influenza surveillance report shows.

A total of 302 cases have been reported so far this season, which began Aug. 29, 2021 and continues until Aug. 27. That’s up from 40 just a month ago.

There have been 60 hospitalizations and four deaths.

‘Double’ risk

If the risks for COVID-19 transmission increase in the fall at the same time the risks for the flu are expected to rise, “then we’ve got, you know, a double kind of risk happening,” said Russell.

“So we want to address that early and making sure that everybody who’s eligible for flu vaccination gets vaccinated as well.”

The province is also “really keen” to have people who fell behind with their routine vaccinations to get caught up on those, she said.

“We wouldn’t want to see a resurgence of vaccine-preventable diseases.”

Adblock test (Why?)



Source link

Continue Reading

Health

COVID-19 vaccines saved 20M lives in 1st year, scientists say – CTV News

Published

 on


Nearly 20 million lives were saved by COVID-19 vaccines during their first year, but even more deaths could have been prevented if international targets for the shots had been reached, researchers reported Thursday.

On Dec. 8, 2020, a retired shop clerk in England received the first shot in what would become a global vaccination campaign. Over the next 12 months, more than 4.3 billion people around the world lined up for the vaccines.

The effort, though marred by persisting inequities, prevented deaths on an unimaginable scale, said Oliver Watson of Imperial College London, who led the new modelling study.

“Catastrophic would be the first word that comes to mind,” Watson said of the outcome if vaccines hadn’t been available to fight the coronavirus. The findings “quantify just how much worse the pandemic could have been if we did not have these vaccines.”

The researchers used data from 185 countries to estimate that vaccines prevented 4.2 million COVID-19 deaths in India, 1.9 million in the United States, 1 million in Brazil, 631,000 in France and 507,000 in the United Kingdom.

An additional 600,000 deaths would have been prevented if the World Health Organization target of 40% vaccination coverage by the end of 2021 had been met, according to the study published Thursday in the journal Lancet Infectious Diseases.

The main finding — 19.8 million COVID-19 deaths were prevented — is based on estimates of how many more deaths than usual occurred during the time period. Using only reported COVID-19 deaths, the same model yielded 14.4 million deaths averted by vaccines.

The London scientists excluded China because of uncertainty around the pandemic’s effect on deaths there and its huge population.

The study has other limitations. The researchers did not include how the virus might have mutated differently in the absence of vaccines. And they did not factor in how lockdowns or mask wearing might have changed if vaccines weren’t available.

Another modelling group used a different approach to estimate that 16.3 million COVID-19 deaths were averted by vaccines. That work, by the Institute for Health Metrics and Evaluation in Seattle, has not been published.

In the real world, people wear masks more often when cases are surging, said the institute’s Ali Mokdad, and 2021’s Delta wave without vaccines would have prompted a major policy response.

“We may disagree on the number as scientists, but we all agree that COVID vaccines saved lots of lives,” Mokdad said.

The findings underscore both the achievements and the shortcomings of the vaccination campaign, said Adam Finn of Bristol Medical School in England, who like Mokdad was not involved in the study.

“Although we did pretty well this time — we saved millions and millions of lives — we could have done better and we should do better in the future,” Finn said.

Funding came from several groups including the WHO; the U.K. Medical Research Council; Gavi, the Vaccine Alliance; and the Bill and Melinda Gates Foundation.

——

AP health and science reporter Havovi Todd contributed

——

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content

____

What questions do you have about travel rules amid COVID-19?

CTVNews.ca wants to hear from Canadians with any questions.

Tell us what you’d like to know when it comes to rules around entering or leaving Canada.

To submit your question, email us at dotcom@bellmedia.ca with your name, location and question. Your comments may be used in a CTVNews.ca story.

Adblock test (Why?)



Source link

Continue Reading

Trending